4//SEC Filing
EYETECH PHARMACEUTICALS INC 4
Accession 0001293941-05-000059
CIK 0001115285operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:09 PM ET
Size
14.1 KB
Accession
0001293941-05-000059
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2005-08-01$1.36/sh+1,850$2,516→ 44,945 total - Sale
Common Stock
2005-08-01$11.35/sh−1,850$20,998→ 43,095 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-08-01−1,850→ 115,921 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2005-08-01−1,850→ 60,479 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying)
Footnotes (1)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.
Documents
Issuer
EYETECH PHARMACEUTICALS INC
CIK 0001115285
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115285
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:09 PM ET
- Size
- 14.1 KB